New Horizon Health
VerifiedResearches and develops technology for early-stage cancer screening.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$607m (Public information from Jun 2024)
Share price
HKD14.14 6606.HK
Hangzhou Zhejiang (HQ)
Deals in current and previous year:
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 21 % | 202 % | 260 % | 144 % | 55 % | 33 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (153 %) | (1064 %) | (1431 %) | (4 %) | 2 % | 17 % | 32 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (183 %) | (1118 %) | (1450 %) | (10 %) | 3 % | 12 % | 19 % |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 45 % | 36 % | 28 % | 12 % | - | - | - |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| investor investor | $0.0 | round | |
| investor investor investor | $0.0 | round | |
| investor investor investor investor | $0.0 | round | |
| investor investor investor | $0.0 | round | |
| investor investor investor investor investor | $0.0 | round | |
| N/A | $263m | IPO | |
| Total Funding | 000k | ||
Related Content
Recent News about New Horizon Health
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
ACQUISITION by Blue Water Vaccines Dec 2023